Načítá se...
Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management
OBJECTIVE—IONA (impact of nicorandil in angina) is a randomised, double blind, placebo controlled trial that will test the hypothesis that nicorandil (target dose of 20 mg twice daily) will reduce the incidence of cardiovascular events in a cohort of men and women with effort angina and additional r...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2001
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1729757/ https://ncbi.nlm.nih.gov/pubmed/11359763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heart.85.6.e9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|